This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Proton pump inhibitor
Endoscopic submucosal dissection
Abe H, Hatta W, Ogata Y, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol. 2021;56:640–50.
Shiratori Y, Niikura R, Ishii N, et al. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study. Gastrointest Endosc. 2021. https://doi.org/10.1016/j.gie.2021.06.032.
Hatta W, Tsuji Y, Yoshio T, et al. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut. 2021;70:476–84.
Hamada K, Uedo N, Tonai Y, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study. J Gastroenterol. 2019;54:122–30.
Conflict of interest
Atsushi Masamune declared that he received lecture honoraria from Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo, Inc., and Mylan N.V. and he received commercial research funding from Otsuka Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., Asahi Kasei Pharma Corp., Eisai Co., Ltd., AbbVie GK, Takeda Pharmaceutical Co., Ltd., and Daiichi Sankyo, Inc. outside the submitted work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Abe, H., Tarasawa, K., Hatta, W. et al. Reply to “Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD”. J Gastroenterol 56, 1109–1110 (2021). https://doi.org/10.1007/s00535-021-01824-w